AVANDIA WARNING | Dallas, Texas Personal Injury Attorney Blog

The US Food & Drug Administration (FDA) issues a consumer warning for persons who use any of the following products

• Avandia – (generic name – rosiglitazone maleate)
• Avandamet – Contains Avandia combined with metformin
• Avandaryl – Contains Avandia combined with glimepiride
• Actos – (pioglitazone HCl) is a type of oral diabetes agents called thiazolidinediones

Glaxo SmithKline manufactures the Avandia drugs and sells them under various generic names including Rosiglitazone Maleate. The drug is currently on the market and is used to treat Type II diabetes. The drugs may cause serious and deadly side effects that the manufacturer failed to warn patients or doctors of including:

• Death
• Heart Attacks
• Congestive Heart Failure
• PPH – Primary Pulmonary Hypertension
• Bone Fractures
• Hepatitis

These dangerous drugs have been on the market since 1999. Even though Glaxo knew of the problems, they failed to provide sufficient warning to the public or to the doctors that prescribed the medication. Avandia can cause heart attacks, Primary Pulmonary Hypertension (PPH), and Congestive Heart Failure in patients taking the drug.

If you have taken Avandia to help treat diabetes and have suffered one or more heart attacks or had symptoms of Pulmonary Hypertension or Congestive Heart Failure, or if you have been diagnosed with either of these serious conditions, call us today. There is a good chance you have been injured by Avandia. You need to get expert medical care and legal advice as soon as possible regarding your claim.

Avandia is sometimes combined with other diabetic medications into a single pill:

  • Avandamet combines two medicines to treat type 2 diabetes Avandia (rosiglitazone maleate) and metformin in one pill.

  • Avandaryl combines two medicines to treat type 2 diabetes – Avandia (rosiglitazone maleate) and glimepiride (a sulfonylurea) in one pill.
  • When your doctor prescribes one of these two combinations, the medication will have a different label but still contain Avandia.

    If you have taken Actos, Avandia, Avandamet or Avandaryl and experienced one or more heart attacks, symptoms of Pulmonary Hypertension, or Congestive Heart Failure, or if your doctor has already diagnosed you with any of these conditions then call us today. Acting now could help save your life.

    The diabetes drug Avandia has been associated with a significantly higher incidence of heart attacks and death, according to a major research analysis. The findings were the result of an analysis of 42 studies involving 15,560 patients who took Avandia and 12,283 who took other drugs or were given a placebo. The study was conducted by doctors at the renowned Cleveland Clinic and reported May 21, 2007 in The New England Journal of Medicine.

    One of those who conducted the latest study, Steven Nissen, chairman of cardiology at the Cleveland Clinic, said it raised “serious concerns about the cardiovascular safety” of Avandia. (He advised that patients first consult with their doctor before discontinuing use of the medication.) Following release of the study, termed a “meta-analysis,” the U.S. Food and Drug Administration issued the following warning: “Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.” The FDA said its own analysis of the drug was ongoing.

    Avandia, prescribed in pill form, is the most widely used oral diabetes treatment, with 2006 sales in excess of $3 billion. The FDA approved it for use in 1999 for the treatment of Type 2 diabetes, the most common form of diabetes. Since that time more than six million people worldwide have taken Avandia.


    Montes Herald Law Group, L.L.P.

    Rachel Montes and Tom Herald

    1121 Kinwest Parkway, Suite 100

    Irving, Texas 75063

    Telephone (214) 522-9401

    Toll Free (877) 529-8899

    Facebook @ Montes Law Group, P.C.

    1 Comment

    1. Berry Junick on June 15, 2012 at 10:34 am

      Hello.This article was extremely interesting, particularly since I was searching for thoughts on this matter last couple of days.

    Leave a Reply